Crystalplex is a nanotechnology company focused on wavelength engineering for high performance LED lighting and display. Our proprietary technology provides the first efficient and stable nanoparticle remote phosphor components for demanding consumer applications.
The lighting industry is undergoing its most fundamental transformation since Thomas Edison. Crystalplex is helping to lead this transition with nano- illumination engineered to deliver LED lighting and display solutions. Made-to-order CCT (color temperature), very high CRI, and peerless optical efficiencies are all enabled with Crystalplex technology.
"Klauf is an expert company in the field of LED lighting, utilizing remote phosphors. When we discovered Crystalplex's innovative breakthroughs, we certainly took notice. Without the dependence on rare earth phosphors from offshore companies and with excellent domestic chemistry, ingenuity, and availability, we knew the lighting industry was in for another game changer. OEMs must take notice."
The promise of nano-illumination technologies to create warm, high-quality light, with high efficiency has been elusive, until now. Crystalplex produces patented industrial-scale nanoparticles and proprietary down-converting diffuser technologies; yielding light to the exact specifications of the most discriminating customers.
Custom diffuser shapes, color termperatures, and CRIs are available to OEMs, utilizing mid-power and high brightness LEDs, and in a vast variety of markets:
Medical & Dental Lighting
Municipality & Street Lamps
Architectural & Linear Luminaires
Retail & Jewelry Display Cases
Cinematography & Photography Lighting
All Types of Consumer Electronics Illumination
Crystalplex, a Pittsburgh company, was founded in 2004 as a biochemistry and diagnostics laboratory, specializing in nanotechnology for the life sciences industry. In 2009, the company expanded its research into optoelectronics and developed high-performance nanocrystals for photoluminescent, electroluminescent and photovoltaic applications. Our first commercial products are highly efficient and reliable nanophosphor-enabled components for solid state lighting OEMs.
Since 2009, Crystalplex has been focused on delivering advanced components to the emerging solid state lighting industry and securing our intellectual property. Our future is bright.
Lianhua Qu, Ph.D., is the Chief Scientific Officer of Crystalplex. Dr. Qu is a world leader in the development of fluorescent nanoparticle technologies. He holds a doctorate in physics from the University of Arkansas.email@example.com
Matt has a 25 year career in nanomaterials and biomaterials research, product development and manufacturing. In the past Matt has developed and commercialized medical devices, infection control devices, medical polymers with engineered surfaces and products for the controlled release of volatile substances. He has been a co-founder of four companies, two of which have had successful exits. His academic research focused on the application of biophotonics and biophysics in the study of cancer cells. His keen interest in the physiology of human vision and color perception is a driving force at Crystalplex. Matt holds 12 patents and has B.S. and M.S. degrees in Cell Physiology from the University of California at Santa Barbara.firstname.lastname@example.org
Dennis is currently the Director of Laboratory Operations at Crystalplex Corporation, based in Pittsburgh PA. He holds a B.S. degree in Nanofabrication Manufacturing Technology (Chemistry) from California University of Pennsylvania. He also has a Certificate of Nanofabrication Manufacturing Technology from Pennsylvania State University.email@example.com
Dr. Hebrank is a successful longtime investor in public and private biotech equities and was the co-founder of and a partner in a successful clinical obstetrics and gynecologic practice in Westmoreland County, Pennsylvania. Dr. Hebrank earned a B.S. in Biomedical Engineering from Vanderbilt University, an M.D. from Tulane University School of Medicine, and completed his residency training in obstetrics and gynecology at Magee-Women’s Hospital, a part of the University of Pittsburgh Medical Center. He completed his M.B.A. at Carnegie Mellon University’s Tepper School of Business. He serves as Crystalplex's executive chair.
Mr. Petzinger is a founder of LaunchCyte LLC, a life sciences incubator that co-founded Crystalplex. He also serves as a director of other LaunchCyte companies, including Immunetrics Inc., Knopp Biosciences, Reaction Biology Corp., and Celsense Inc.. He is also a director of Lipella Pharmaceuticals Inc. and WESA 90.5 FM, Pittsburgh. Prior to co-founding LaunchCyte, he spent 22 years at The Wall Street Journal, where he served as Washington economics editor, deputy Washington bureau chief, millennium editor, and weekly columnist. He has also written three business books, two selected as notable books of the year by The New York Times. He received his B.S. in Journalism from Northwestern University, where he was a Richter International Scholar.
Matt has a 25 year career in nanomaterials and biomaterials research, product development and manufacturing. In the past Matt has developed and commercialized medical devices, infection control devices, medical polymers with engineered surfaces and products for the controlled release of volatile substances. He has been a co-founder of four companies, two of which have had successful exits. His academic research focused on the application of biophotonics and biophysics in the study of cancer cells. His keen interest in the physiology of human vision and color perception is a driving force at Crystalplex. Matt holds 12 patents and has B.S. and M.S. degrees in Cell Physiology from the University of California at Santa Barbara.
Mr. Mitchell serves as Vice President and General Counsel for NOVA Chemicals Inc. following stints at Merck & Co. Inc. and Oakwood Laboratories. He brings to Crystalplex more than 30 years of intellectual property, licensing, litigation, commercial, and governance experience in the chemical and pharmaceutical industries. He holds a B.S. in chemical engineering and an MBA from the University of Pittsburgh and earned his J.D. at Duquesne University School of Law.
Dr. Sieper has over 35 years experience as an oncologist, business executive and investor. He received his training at Kirksville College of Osteopathic Medicine which was followed by residencies in radiation oncology and nuclear medicine at Thomas Jefferson University Hospital and the University of Pennsylvania. Dr. Sieper headed a successful oncology practice in Greensburg, Pennsylvania and currently consults in San Francisco and Pittsburgh with the University of Pittsburgh Medical Center (UPMC).
Mr. Oristano is CEO of Reaction Biology Corp. of Malvern, Pa., and is President of Alda Inc., a private investment firm. In addition, he serves on the board of Spōk (Nasdaq: SPOK) and its audit committee. He is also on the board of Crystalplex Corporation. From 1993 to 1999, Mr. Oristano was Chairman and CEO of People's Choice TV Corp, a public wireless TV and internet company, which he founded in 1988 and sold to Sprint in 1999. Mr. Oristano has a degree in physics from Rennselaer Polytechnic Institute.
Mr. O’Hanlon serves as President and CEO of Celsense Inc. Mr. O’Hanlon was previously a Managing Director of Cornerstone Capital Advisors, of Pittsburgh, PA, where he provided financial and operating advice, interim management, and corporate finance services to privately held businesses. While at Cornerstone, he was involved in the founding of numerous new ventures, spin-offs, and re-starts of distressed companies. Prior to joining Cornerstone in 2001, he held a number of executive management positions with National City and Mellon Bank. Mr. O’Hanlon serves on the boards of several private companies. He previously served on the boards of the Pittsburgh Technology Council, the CEO Venture Fund, and the Pittsburgh Regional Healthcare Initiative. He received a B.S. in industrial management from Georgia Institute of Technology and an MBA from Robert Morris College in 1980.
2403 Sidney Street, Suite 270
Pittsburgh, PA 15203
fax: +1 412.787.1526